Special Investigation For Genotropin(Sga Long Follow-up)
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Somatrogon (Primary)
- Indications Growth disorders; Short stature
- Focus Therapeutic Use
- Sponsors Pfizer
- 17 Apr 2017 Status changed from active, no longer recruiting to completed.
- 06 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 10 Mar 2017.
- 03 Mar 2017 Planned End Date changed from 1 Feb 2017 to 10 Mar 2017.